Shanghai Fosun Pharmaceutical Reports 1H Results
Ardelyx Announces Acceptance Of New Drug Application For Tenapanor For Hyperphosphatemia In China; Triggers $2M Milestone Payment To Ardelyx Under The Terms Of The License Agreement Between Co And Shanghai Fosun Pharmaceutical Industrial Development Co.
INNOVATE Corp's MediBeacon Receives $10M In Amended Agreements With Huadong Medicine
Market Chatter: Fosun Pharma in Talks With Beijing Over Pfizer-BioNTech's COVID-19 Vaccine; Shares Fall 4%
Shanghai Fosun Pharmaceutical reports FY results
Fosun Pharma Forms Two Funds to Invest in New Drug-Related Projects